Metraipolis › archive › dc_885f83aa8fea

Propofol provides a significant survival advantage in sepsis-associated encephalopathy: A retrospective cohort study investigating one-year all-cause mortality — Europe PMC PMID:41642831

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41642831
DOI
10.1371/journal.pone.0340371
License (as archived)
solo-consultazione
Archived
2026-11-06T02:21:02.535Z
SHA-256 of the archived text
2d7a198f069cfda92ac9e25ea163cea7e368becba9f02e6876c81d6ed54844e7
Stable URL of this page
https://metraipolis.com/documento/dc_885f83aa8fea

How to cite

Propofol provides a significant survival advantage in sepsis-associated encephalopathy: A retrospective cohort study investigating one-year all-cause mortality — Europe PMC PMID:41642831 — Europe PMC (en), https://europepmc.org/article/MED/41642831 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_885f83aa8fea (Metraipolis archive dc_885f83aa8fea, sha256 2d7a198f069cfda92ac9e25ea163cea7e368becba9f02e6876c81d6ed54844e7)
BibTeX
@misc{dc885f83aa8fea,
  title = {Propofol provides a significant survival advantage in sepsis-associated encephalopathy: A retrospective cohort study investigating one-year all-cause mortality — Europe PMC PMID:41642831},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41642831},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_885f83aa8fea; sha256 2d7a198f069cfda92ac9e25ea163cea7e368becba9f02e6876c81d6ed54844e7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41642831. Agents can read the archived copy with the MCP tool read_document.